According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are โน14.91 Billion. In 2025 the company made an earning of โน493.69 Billion, an increase over its 2024 earnings that were of โน451.15 Billion. The earnings displayed on this page is the company's Pretax Income.